[vc_row][vc_column width="1/4" css=".vc_custom_1539614923019{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="758" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 01" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][vc_column width="1/4" css=".vc_custom_1539614931980{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="759" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 02" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][vc_column width="1/4" css=".vc_custom_1539614940491{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="760" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 03" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][vc_column width="1/4" css=".vc_custom_1539615320522{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="761" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 04" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][/vc_row][vc_row][vc_column width="1/4" css=".vc_custom_1539614949831{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="762" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 04" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][vc_column width="1/4" css=".vc_custom_1539615303892{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="763" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 06" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][vc_column width="1/4" css=".vc_custom_1539614958550{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="764" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 07" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][vc_column width="1/4" css=".vc_custom_1539615312222{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}"][vc_single_image image="765" img_size="full" alignment="center" style="vc_box_circle_2"][vc_custom_heading text="Member 08" font_container="tag:h2|font_size:18px|text_align:center|line_height:20px" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal"][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height="60px"][vc_custom_heading text="Pembicara dan Title video" font_container="tag:h2|font_size:24|text_align:left" google_fonts="font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal"][vc_empty_space height="30px"][vc_column_text]1. Introduction
<ul>
 	<li><strong>Dr. Elvieda Sariwati :</strong> National Policy on Malaria Control and Malaria Situation in Indonesia</li>
 	<li><strong>Dr. Maria Endang Sumiwi:</strong> Malaria Global Epidemiology: Global and Regional Status and Tools for Malaria Control</li>
 	<li><strong>Dr. J. Rini Poespoprodjo:</strong> Antimalarial drug resistance</li>
</ul>
&nbsp;

2. Diagnosis
<ul>
 	<li><strong>Prof. Inge Soetanto:</strong> Diagnosis of Malaria Parasites</li>
 	<li>Practice on malaria diagnosis</li>
</ul>
&nbsp;

3. Uncomplicated Malaria
<ul>
 	<li><strong>Dr. J. Rini Poespoprodjo:</strong> Uncomplicated Malaria and treatment</li>
 	<li><strong>Dr. Paul Hariyanto:</strong> Case discussion 1: diagnosis, management and supporting system</li>
 	<li><strong>Dr. Paul Hariyanto:</strong> Case discussion 2: diagnosis, management and supporting system</li>
 	<li><strong>Dr. Agung Nugroho:</strong> Case discussion 3: diagnosis, management and supporting system</li>
</ul>
&nbsp;

4. Severe Malaria
<ul>
 	<li><strong>Dr. Paul Hariyanto: </strong>Overview of Severe Malaria and Antimalarial Drug for Severe Malaria</li>
 	<li><strong>Dr. Agung Nugroho:</strong> Pathophysiology and Pathogenesis of Severe Malaria</li>
 	<li><strong>Dr. Paul Hariyanto: </strong>Manifestation of Organ Failure in Malaria and its Management</li>
 	<li><strong>Dr. Agung Nugroho: </strong>Malaria and co-morbidities</li>
 	<li><strong>Dr. Agung Nugroho: </strong>Case discussion 4 : Management of malaria in limited facilities and referral preparations</li>
 	<li><strong>Dr. Agung Nugroho: </strong>Case discussion 5 : Management of malaria in limited facilities and referral preparations</li>
 	<li><strong>Dr. Paul Hariyanto: </strong>Case discussion 6 : Management of malaria in limited facilities and referral preparations</li>
 	<li><strong>Dr. Paul Hariyanto: </strong>Case discussion 7 : Management of malaria in limited facilities and referral preparations</li>
</ul>
&nbsp;

5. Vunerable population
<ul>
 	<li><strong>Dr. J. Rini Poespoprodjo:</strong> Malaria in children</li>
 	<li><strong>Dr. IK. Marthayasa:</strong> Malaria in pregnancy</li>
 	<li><strong>Dr. Agung Nugroho: </strong>Malaria prevention and chemoprophylaxis</li>
</ul>
&nbsp;

6. Entomology
<ul>
 	<li><strong>Bonny Sebayang:</strong> Malaria entomology for clinicians</li>
 	<li>Field practice on malaria entomology</li>
</ul>
[/vc_column_text][/vc_column][/vc_row]